![Daniel Palmacci](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 879 730 $ au 31/07/2026
Daniel Palmacci is currently the President-Lonzas Cell & Gene Division at MorphoSys AG.
He started this position in 2022.
Prior to his current role, he graduated from Humboldt-Universität zu Berlin.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
Lonza Group AG
 Lonza Group AG BiotechnologyHealth Technology Develops and manufactures, biologics, biopharmaceuticals, small molecules & health ingredients 0 % | 31/12/2025 | 1 266 ( 0 % ) | 879 730 $ | 31/07/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
| MORPHOSYS AG | Directeur Technique/Scientifique/R&D | 01/11/2022 |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 2 |
|---|---|
MorphoSys AG
 MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
Humboldt-Universität zu Berlin
 Humboldt-Universität zu Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
